Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Zevra Therapeutics (ZVRA) over the last 8 years, with Q3 2025 value amounting to 0.23.

  • Zevra Therapeutics' Debt Ratio fell 2618.91% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year decrease of 2618.91%. This contributed to the annual value of 0.33 for FY2024, which is 3460.81% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Debt Ratio of 0.23 as of Q3 2025, which was down 2618.91% from 0.24 recorded in Q2 2025.
  • Zevra Therapeutics' 5-year Debt Ratio high stood at 0.4 for Q2 2024, and its period low was 0.01 during Q1 2021.
  • Over the past 5 years, Zevra Therapeutics' median Debt Ratio value was 0.24 (recorded in 2025), while the average stood at 0.21.
  • Per our database at Business Quant, Zevra Therapeutics' Debt Ratio surged by 23535.21% in 2024 and then crashed by 4136.78% in 2025.
  • Quarter analysis of 5 years shows Zevra Therapeutics' Debt Ratio stood at 0.01 in 2021, then soared by 1185.04% to 0.11 in 2022, then surged by 123.62% to 0.25 in 2023, then soared by 34.61% to 0.33 in 2024, then tumbled by 32.05% to 0.23 in 2025.
  • Its Debt Ratio was 0.23 in Q3 2025, compared to 0.24 in Q2 2025 and 0.35 in Q1 2025.